Stocks · Health care · Biological Products, (No Diagnostic Substances)

Voyager Therapeutics, Inc.

VYGR Clue Score26

United States Fiscal year ends December CIK 0001640266 Results filed 6 Aug 2026

Add to watchlist

By person

7 insiders · 11 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Alfred Sandrock

President and CEO

—

$184.45K (4) scheduled

−$184.45K

472,549

0.7669%

$1.83M

+43.1%

Robin Swartz

President

—

$55.29K (3) scheduled

−$55.29K

267,988

0.4349%

$1.04M

+125.5%

Todd Alfred Carter

Chief Scientific Officer

—

$40.62K (3) scheduled

−$40.62K

178,718

0.2900%

$691.64K

+104.0%

Nathan D. Jorgensen

Chief Financial Officer

—

$17.60K (1) scheduled

−$17.60K

151,416

0.2457%

$585.98K

+89.3%

Toby Ferguson

Chief Medical Officer

—

183,914

0.2985%

$711.75K

+75.2%

Sandell Jacquelyn Fahey

Chief Legal Officer

—

123,143

0.1998%

$476.56K

+43.2%

Gregory L. Shiferman

SVP and General Counsel

—

50,000

0.0811%

$193.50K

—

Voyager Therapeutics, Inc.

What the insiders did Net selling

By person